EKF Diagnostics Holdings plc (LON:EKF) Insider Gavin T. Jones Acquires 50,000 Shares of Stock

EKF Diagnostics Holdings plc (LON:EKF) insider Gavin T. Jones acquired 50,000 shares of the company’s stock in a transaction that occurred on Tuesday, March 25th. The stock was purchased at an average cost of GBX 22 ($0.28) per share, for a total transaction of £11,000 ($14,162.48).

EKF Diagnostics Stock Performance

Shares of EKF stock opened at GBX 22.90 ($0.29) on Thursday. EKF Diagnostics Holdings plc has a 12-month low of GBX 18.40 ($0.24) and a 12-month high of GBX 33.80 ($0.44). The company has a debt-to-equity ratio of 0.34, a current ratio of 4.60 and a quick ratio of 1.77. The firm has a market capitalization of £101.78 million, a price-to-earnings ratio of 21.31 and a beta of 0.57. The business has a 50 day simple moving average of GBX 23.23 and a 200 day simple moving average of GBX 25.85.

EKF Diagnostics (LON:EKF) last released its quarterly earnings results on Tuesday, March 25th. The company reported GBX 1.38 ($0.02) earnings per share (EPS) for the quarter. EKF Diagnostics had a return on equity of 7.03% and a net margin of 9.37%. On average, equities research analysts anticipate that EKF Diagnostics Holdings plc will post 2.2987842 EPS for the current year.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.